The global AI in healthcare market has witnessed an exponential growth trajectory, with its valuation surging from $4,836.87 million in 2019 to a projected $99,491.58 million by 2027. T his report ...
Two types of amylin-based treatments for the treatment of obesity are currently being developed: dual amylin and calcitonin receptor agonists (DACRAs) that target both the amylin and calcitonin ...